Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc.

Overview
Date Founded

1994

Headquarters

385 East Colorado Boulevard,Suite 299,Pasadena, CA 91101

Type of Company

Public

Employees (Worldwide)

470

Industries

Trusts & Funds
Real Estate
Real Estate Investment Trusts

Company Description

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust. It engages in the ownership, operation, development, and redevelopment of life science and technology properties. The firm also provides a space for lease to the life science and technology industries, which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Contact Data
Trying to get in touch with decision makers at Alexandria Real Estate Equities, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Chief Executive Officer & Co-Chief Investment Officer

Co-Chief Executive Officer

Executive Vice President, Real Estate Legal Affairs & Assistant Secretary

President & Chief Financial Officer

Co-Chief Operating Officer & Chief Strategic Transactions Officer

Co-Chief Operating Officer

General Counsel & Secretary

Chief Development Officer

Chief Accounting Officer

Senior Vice President-Regional Market Director, Seattle

Board of Directors

Managing Partner, Life Science Healthcare Investment Team at SVB Capital

President & Executive Director at Foundation for the National Institutes of Health, Inc.

Partner at Kirkland & Ellis LLP

Co-Founder at O'Brien/Atkins Associates PA

Co-Founder at Renaissance Macro Research LLC

Partner, New York, Raleigh & Washington at Cain Global Partners LLC

Chief Financial Officer at Industrial Realty Group LLC

Senior Management Consultant at Alexandria Real Estate Equities, Inc.

Co-Founder at Alexandria Real Estate Equities, Inc.

Paths to Alexandria Real Estate Equities, Inc.
Potential Connections via
Relationship Science
You
Alexandria Real Estate Equities, Inc.
Owners & Shareholders
Details Hidden

APG US’ portfolio includes Fixed Income, Private Real Estate, and Infrastructure. The Fixed Income Portfolios utilizes bottom-up issue selection combined with top-down duration management and sector allocation in a disciplined, quantifiable, and reproducible manner. The firm invests in a broad spectrum of fixed income sectors that convey different risks, diversification of return and alpha sources are essential elements of the investment process. The Listed Real Estate strategy uses fundamental analysis to form the basis for investment decisions. The Private Real Estate investment strategy uses quantitative analysis, which relies upon objective analysis of market conditions and asset valuation and underwriting, in addition to fundamental research, to form the basis for evaluating investment opportunities. The Infrastructure investment strategy focuses on private infrastructure businesses and assets.

Details Hidden

At Principal Global Investors, designing and delivering the investment solutions that our clients need, when they need them, is our singular and constant focus—and the diverse group of specialized investment boutiques that comprise our asset management business are an important factor in this endeavor. We offer investment strategies that support the growing demand for income and yield, and we leverage our quality-focused alpha and beta offerings in both developed and emerging markets. Our multi-boutique strategy is designed to provide comprehensive investment solutions for our clients. Our growing network of specialized investment boutiques and teams delivers focused areas of expertise in several areas: asset allocation, equities, fixed income, real estate, currency management, stable value, and other structured investment strategies.

Details Hidden

PrinREI offers a number of real estate investment strategies relating to direct and indirect investment in real estate and real estate interests. The strategies fall into four different areas: private equity real estate, real estate equity securities issued by real estate investment trusts and other companies involved in the commercial real estate business, private real estate debt, and public real estate debt securities such as commercial mortgage backed securities (CMBS). They make their investment management decisions using a relative value approach. This team-based, time-tested process includes in-depth research and focuses on maximizing investment returns that match your risk tolerances and preferences. The foundation of PrinREI’s investment decisions is a combination of top-down economic and sector analysis with bottom-up asset analysis, giving their investment professionals the insights they need to successfully execute strategies. Their macroeconomic and microeconomic research incorporates analysis of economic, demographic, political, technological, property and capital market trends. Data from their equity and debt transaction, leasing and asset management portfolio is combined with external and capital markets knowledge to develop forecasts for the metropolitan statistical areas that they cover.

Recent Transactions
Details Hidden

Alexandria Real Estate Equities, Inc. raised money in a private placement transaction

Details Hidden

Alexandria Real Estate Equities, Inc. raised money in a private placement transaction

Details Hidden

Alexandria Real Estate Equities, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Underwriter

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Underwriter

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Co-Head of Americas Real Estate Investment Banking

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Legal Advisor

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Assistant General Counsel

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner at Skadden, Arps, Slate, Meagher & Flom LLP

Legal Advisor

Partner at Skadden, Arps, Slate, Meagher & Flom LLP

Advisor

Member-Economic Development Advisory Group at Massachusetts Biotechnology Council

Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. The firm's products include ONPATTRO, GIVLAARI, and OXLUMO. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The Company's key programs include: RELVAR™ or BREO™ ELLIPTA™(FF/VI), ANORO™ ELLIPTA™ (UMEC/VI) and MABA (Bifunctional Muscarinic Antagonist-Beta2 Agonist), each partnered with GlaxoSmithKline plc, and our oral Peripheral Mu Opioid Receptor Antagonist program. By leveraging its proprietary insight of multivalency to drug discovery, Theravance is pursuing a best-in-class strategy designed to discover superior medicines in areas of significant unmet medical need. Our objective is to discover, develop and commercialize new medicines with superior efficacy, convenience, tolerability and/or safety.

Key Stats and Financials As of 2020
Market Capitalization
$23.1B
Total Enterprise Value
$31.6B
Earnings Per Share
$6.01
Revenue
$1.88B
Net Profit
$761M
Enterprise Value / Sales
16.83x
TEVNet Income
41.5x
Debt TEV
0.25x
Total Debt
$7.91B
Total Equity
$13.4B
EBITDAMargin
84.56%
Enterprise Value EBITDAOperating
19.69x
EBITDA
$1.59B
Three Year Compounded Annual Growth Rate Of Revenue
18.92%
Non-Profit Donations & Grants
Investments
Details Hidden

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.

Details Hidden

Cradle Genomics, Inc. engages in researching and developing life sciences. The company was founded by Randy Armant, Richard Shippy and Sascha Drewlo and is headquartered in San Diego, CA.

Details Hidden

Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alexandria Real Estate Equities, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alexandria Real Estate Equities, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Alexandria Real Estate Equities, Inc..